Special Supplement, November 2023

Afficher Special Supplement, November 2023

Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill

Publié: 2023-11-23

Articles

Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases The Powerful Pill

Neeraj Narula, MD, MPH, FRCPC, Hasan Hamam, MD, MSC

2–11
- PDF (en)